Skip to main content
Clinical Trials/NCT02262195
NCT02262195CompletedNot Applicable

Dysfunctional Hemoglobin Pulse Co-ox

Nonin Medical, Inc1 site in 1 country62 target enrollmentStarted: October 2014Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
62
Locations
1
Primary Endpoint
Evaluate carboxyhemoglobin over the range of 0-15 percent as assessed by co-oximetry

Study Overview

Brief Summary

The purpose of the study is to determine if a new pulse oximeter accurately detects carboxyhemoglobin and methemoglobin when intentionally increased in the blood.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Subjects does not have significant medical problems
  • Subject is willing to provide written informed consent
  • Subject is between 18 and 45 years of age

Exclusion Criteria

  • Has a BMI greater than 31
  • Has had any relevant injury at the sensor location site
  • Has deformities or abnormalities that may prevent proper application of the device under test
  • Has a known respiratory condition
  • Is currently a smoker
  • Has a known heart or cardiovascular condition
  • Is currently pregnant
  • Is female and actively trying to get pregnant
  • Has a clotting disorder
  • Is known to have a hemoglobinopathy such as (anemia, bilirubinemia, sickle-cell anemia, inherited or congenital methemoglobinemia)
  • The subject has a COHb greater than 3% or MetHb greater than 2%
  • Has taken blood thinners or medication with aspirin within the last 24 hours
  • Has unacceptable collateral circulation from the ulnar artery
  • Has donated more than 300 mL of blood within one month prior to start of study
  • Is unwilling or unable to provide written informed consent to participate in the study
  • Is unwilling or unable to comply with the study procedures
  • Has another health condition which in the opinion of the principal investigator makes him/her unsuitable for testing

Outcomes

Primary Outcomes

Evaluate carboxyhemoglobin over the range of 0-15 percent as assessed by co-oximetry

Time Frame: 4 hours

Evaluate methemoglobin over the range of 0-15 percent as assessed by co-oximetry

Time Frame: 4 hours

Secondary Outcomes

  • Determine oxygen saturation accuracy in conditions of elevated methemoglobin(4 hours)
  • Determine oxygen saturation accuracy in conditions of elevated carboxyhemoglobin(4 hours)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Dysfunctional Hemoglobin | Clinical Trial